ExactScience vs Oatmealhealth
Side-by-side comparison · Updated May 2026
| Description | Exact Sciences Corp. is a leading molecular diagnostics company focused on transforming cancer care through prevention, early detection, and treatment guidance. Their cutting-edge product portfolio includes non-invasive screening tests like Cologuard® for colorectal cancer, Oncotype DX® for predicting cancer recurrence, and OncoExTra® for genomic profiling. The company also offers Riskguard™ for hereditary cancer risk assessment and is pioneering multi-cancer early detection tests. Committed to innovation and scientific validation, Exact Sciences plays a pivotal role in cancer diagnostics, earning endorsements from clinical guidelines and continuous certification as a Great Place to Work®. | Oatmeal Health is a cutting-edge, AI-driven platform dedicated to enhancing health equity through advanced cancer screening and early detection, specifically targeting underserved Federally Qualified Health Center (FQHC) patient populations. Their comprehensive service package includes expert primary care support, thorough radiology risk assessments, and state-of-the-art AI and biotech innovations to facilitate early diagnosis. By partnering with various healthcare stakeholders, Oatmeal Health aims to reduce disparities across the cancer care continuum and ensure that underrepresented communities receive the care they deserve. |
| Category | Healthcare | Healthcare |
| Rating | No reviews | No reviews |
| Pricing | Free | Pricing unavailable |
| Starting Price | Free | N/A |
| Plans |
| — |
| Use Cases |
|
|
| Tags | molecular diagnosticscancer carepreventionearly detectiontreatment guidance | AI-driven platformhealth equitycancer screeningearly detectionFederally Qualified Health Center |
| Features | ||
| Comprehensive suite of cancer tests across the care continuum, including early detection and screening. | ||
| Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening. | ||
| Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment. | ||
| Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection. | ||
| Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits. | ||
| OncoExTra® test for aiding late-stage cancer therapy selection. | ||
| Supports patient and provider through logins for test ordering and results tracking. | ||
| Backed by extensive scientific research, publications, and clinical studies. | ||
| Engages in community outreach and health equity initiatives. | ||
| AI-driven cancer screening | ||
| Focus on underserved FQHC patient populations | ||
| Expert primary care support | ||
| Comprehensive radiology risk assessments | ||
| Cutting-edge AI and biotech advancements | ||
| Local nurse and radiologist support | ||
| No cost to clinics for additional staff support | ||
| Partnerships with a variety of healthcare stakeholders | ||
| Reduces disparities in cancer care | ||
| Ensures early diagnosis for improved health outcomes | ||
| View ExactScience | View Oatmealhealth | |
Modify This Comparison
Also Compare
Explore more head-to-head comparisons with ExactScience and Oatmealhealth.